Evidence map›Paper›PMID 25305075›Full record

ArticleHuman molecular genetics2015

Mitochondrial m.1584A 12S m62A rRNA methylation in families with m.1555A>G associated hearing loss.

Mary O'Sullivan, Paul Rutland, Deirdre Lucas, Emma Ashton, Sebastian Hendricks, Shamima Rahman, Maria Bitner-Glindzicz

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Precision mitochondrial medicine.Cambridge prisms. Precision medicine · 2023
    Review
  5. Review
  6. Human Mitoribosome Biogenesis and Its Emerging Links to Disease.International journal of molecular sciences · 2021
    Review
  7. [Progress in genetic susceptibility to aminoglycoside-induced deafness].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Mitoepigenetics and Its Emerging Roles in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Towards the Prevention of Aminoglycoside-Related Hearing Loss.Frontiers in cellular neuroscience · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Mary O'SullivanGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Paul RutlandGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Deirdre LucasNuffield Hearing and Speech Centre, Royal National Throat Nose and Ear Hospital, London WC1X 8DA, UK.
Emma AshtonNE Thames Regional Genetics Service.
Sebastian HendricksBarnet and Chase Farm Hospitals NHS Trust, Enfield, Middlesex EN2 8JL, UK and.
Shamima RahmanGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK, Metabolic Department, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
Maria Bitner-GlindziczGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK, Centre for Auditory Research, UCL Ear Institute, London WC1X 8EE, UK maria.bitner@ucl.ac.uk.
University College London · GBChase Farm Hospital · GBGreat Ormond Street Hospital · GBRegional Health · USRoyal National Throat Nose and Ear Hospital · GB

Funding

Action on Hearing Loss G47
6 · The paper itself

Abstract

The mitochondrial DNA mutation m.1555A>G predisposes to hearing loss following aminoglycoside antibiotic exposure in an idiosyncratic dose-independent manner. However, it may also cause maternally inherited hearing loss in the absence of aminoglycoside exposure or any other clinical features (non-syndromic hearing loss). Although m.1555A>G was identified as a cause of deafness more than twenty years ago, the pathogenic mechanism of this mutation of ribosomal RNA remains controversial. Different mechanistic concepts have been proposed. Most recently, evidence from cell lines and animal models suggested that patients with m.1555A>G may have more 12S rRNA N6, N6-dimethyladenosine (m(6) 2A) methylation than controls, so-called 'hypermethylation'. This has been implicated as a pathogenic mechanism of mitochondrial dysfunction but has yet to be validated in patients. 12S m(6) 2A rRNA methylation, by the mitochondrial transcription factor 1 (TFB1M) enzyme, occurs at two successive nucleotides (m.1584A and m.1583A) in close proximity to m.1555A>G. We examined m(6) 2A methylation in 14 patients with m.1555A>G, and controls, and found all detectable 12S rRNA transcripts to be methylated in both groups. Moreover, different RNA samples derived from the same patient (lymphocyte, fibroblast and lymphoblast) revealed that only transformed cells contained some unmethylated 12S rRNA transcripts, with all detectable 12S rRNA transcripts derived from primary samples m(6) 2A-methylated. Our data indicate that TFB1M 12S m(6) 2A rRNA hypermethylation is unlikely to be a pathogenic mechanism and may be an artefact of previous experimental models studied. We propose that RNA methylation studies in experimental models should be validated in primary clinical samples to ensure that they are applicable to the human situation.

Indexed as

Genes, MitochondrialMutationAdolescentBase SequenceChildChild, PreschoolFamilyFemaleGenetic Association StudiesHearing LossHumansInfantMaleMethylationNucleic Acid ConformationPedigreeRNA, RibosomalRNA, ribosomal, 12S

Identifiers

PMID25305075
PMCPMC4986548
OpenAlexW2138584833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.